Credit: NIH Scientists at The Scripps Research Institute (TSRI) have made another important advance in HIV vaccine design. This vaccine candidate indeed prompted the immune system to produce antibodies that neutralized the corresponding clade C HIV strain when tested in non-human primates. "Clade C HIV strains are responsible for the majority of infections worldwide." Because this is the only antibody target on the surface of HIV, an effective HIV vaccine will have to trigger the body to produce antibodies to neutralize the virus by blocking these activities. The researchers finally had a map of the clade C glycoprotein.
Scientists jump hurdle in HIV vaccine design
This vaccine candidate indeed prompted the immune system to produce antibodies that neutralised the corresponding clade C HIV strain when tested in non-human primates. Because this is the only antibody target on the surface of HIV, an effective HIV vaccine will have to trigger the body to produce antibodies to neutralise the virus by blocking these activities. Solving the clade C structureHIV mutates rapidly, so there are countless strains of HIV circulating around the world. "Clade C HIV strains are responsible for the majority of infections worldwide."The scientists faced a big challenge: The clade C envelope glycoprotein is notoriously unstable and the molecules are prone to falling apart. The researchers finally had a map of the clade C glycoprotein.
collected by :Lucy William
No comments:
Post a Comment